Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
4,594 results
- cAd3-Marburg Vaccine in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of cAd3-Marburg Vaccine in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03475056).
- CADDIEIndependent statistical analysis of CADDIE Trial - Computer Aided Diagnosis and Detection for Intelligent Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CADENCE-MISIndependent statistical analysis of EDWARDS INTUITY Valve System CADENCE-MIS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02672553).
- CADETTEIndependent statistical analysis of Cardiac Displacement From Third Trimester to Early Childhood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02583763).
- CAESARIndependent statistical analysis of Candesartan Effect in Second Stage Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621153).
- CAFIndependent statistical analysis of Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CAFETERIAIndependent statistical analysis of Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CAFIIndependent statistical analysis of Coil Assisted Flow Diversion Safety and Performance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04187573).
- Calcium Absorption in Patients With Rothmund-Thomson Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Calcium Absorption in Patients With Rothmund-Thomson Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304407).
- Calf Deep Vein Thrombosis Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of Calf Deep Vein Thrombosis Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03590743).
- CALIPSOIndependent statistical analysis of CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CALMextIndependent statistical analysis of CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext): primary endpoint results, effect estimate with confidence interval, sample-size…
- Caminamos: A Smartphone App to Connect With Walking Partners: Complete Statistical AnalysisIndependent statistical analysis of Caminamos: A Smartphone App to Connect With Walking Partners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03059901).
- CAMPBELIndependent statistical analysis of CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: Complete Statistical AnalysisIndependent statistical analysis of Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: Complete Statistical AnalysisIndependent statistical analysis of Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CAN QuitIndependent statistical analysis of Connecting Alaska Native People to Quit Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645941).
- CANDLEIndependent statistical analysis of Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Cangrelor Ticagrelor Transition Study: Complete Statistical AnalysisIndependent statistical analysis of Cangrelor Ticagrelor Transition Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01766466).
- Cannabidiol and Management of Endometriosis Pain: Complete Statistical AnalysisIndependent statistical analysis of Cannabidiol and Management of Endometriosis Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04527003).
- Cannabidiol in Youth Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Cannabidiol in Youth Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05317546).
- Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00588731).
- Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control: Complete Statistical AnalysisIndependent statistical analysis of Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05477875).
- Cannabinoids for Pain Control During Medical Abortion: Complete Statistical AnalysisIndependent statistical analysis of Cannabinoids for Pain Control During Medical Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03604341).
- CANOPY-2Independent statistical analysis of Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy:…
- CANTATAIndependent statistical analysis of CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cap-assisted Water Immersion Versus Water Immersion Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Cap-assisted Water Immersion Versus Water Immersion Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01547247).
- CAP-CholIndependent statistical analysis of Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients: primary endpoint results,…
- Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates: Complete Statistical AnalysisIndependent statistical analysis of Cap-fitted Colonoscopy: a Randomized, Tandem Colonoscopy Study of Adenoma Miss Rates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CAP’ONCOIndependent statistical analysis of CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CAPEIndependent statistical analysis of Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05512962).
- Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies: Complete Statistical AnalysisIndependent statistical analysis of Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00347438).
- Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction: Complete Statistical AnalysisIndependent statistical analysis of Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction: primary endpoint results, effect estimate with confidence…
- CAPICAIndependent statistical analysis of Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02202577).
- CAPITALCHILLIndependent statistical analysis of Mild Versus Moderate Therapeutic Hypothermia in Out-of-hospital Cardiac Arrest Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02011568).
- CAPPSIndependent statistical analysis of Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00135707).
- CAPYBARAIndependent statistical analysis of A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CARAVAGGIOIndependent statistical analysis of Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00514540).
- Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary: Complete Statistical AnalysisIndependent statistical analysis of Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Cardiac Rehabilitation Peer Mentorship: Complete Statistical AnalysisIndependent statistical analysis of Cardiac Rehabilitation Peer Mentorship: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02204449).
- CARDIOSA-12Independent statistical analysis of Hypoglossal Nerve Stimulation on Cardiovascular Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03359096).
- Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults: Complete Statistical AnalysisIndependent statistical analysis of Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CARDSIndependent statistical analysis of Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04427280).